Search Results
SAIC's MG to open second Europe parts centre by the summer
By Gilles Guillaume PARIS (Reuters) - MG Motors, a unit of Chinese automaker SAIC, will open a second European parts centre by the summer of 2024 in France to meet the country's growing demand for its...
Thomson Reuters Mar 14, 2024
Novo Nordisk resumes shipments of Wegovy 1.7 mg dose in US
(Reuters) - Novo Nordisk said on Friday it resumed shipments of weight loss drug Wegovy in the 1.7 milligram dose in early January, following a short-term stock-out in the U.S. in mid-December last ye...
Thomson Reuters Jan 13, 2024
Sweden bans Huawei, ZTE gear for use by firms taking part in 5G spectrum auction
STOCKHOLM (Reuters) - The Swedish Post and Telecom Authority (PTS) on Tuesday banned the use of products from China's Huawei and ZTE by companies taking part in a 5G spectrum auction scheduled for nex...
Syndicated Content Oct 20, 2020
Sun Pharma latest to sell COVID-19 drug favipiravir in India
BENGALURU (Reuters) - India's Sun Pharmaceutical Industries Ltd said on Tuesday it would soon begin selling its version of favipiravir, becoming the latest generic drugmaker to supply the antiviral to...
Syndicated Content Aug 04, 2020
India's Hetero prices experimental COVID-19 drug remdesivir at $71 per 100 mg vial
BENGALURU (Reuters) - India's Hetero Labs Ltd has priced its generic version of remdesivir, Gilead's experimental COVID-19 drug, at 5,400 rupees ($71) per 100-milligram vial, the drugmaker said on Wed...
Syndicated Content Jun 24, 2020
Mylan to launch generic remdesivir version in India at $64 per 100 mg vial
BENGALURU (Reuters) - Drugmaker Mylan NV said on Monday it would launch its generic version of Gilead Sciences Inc's COVID-19 treatment remdesivir in India this month at 4,800 rupees ($64.31) per 100 ...
Syndicated Content Jul 06, 2020
Gilead abandons filgotinib for rheumatoid arthritis in U.S.
(Reuters) - Gilead Sciences Inc said on Tuesday it had decided not to pursue the U.S. Food and Drug Administration's approval of its experimental rheumatoid arthritis treatment, filgotinib, following ...
Syndicated Content Dec 15, 2020
India's Sovereign Pharma dispatches first batch of remdesivir to Cipla
BENGALURU (Reuters) - India's Sovereign Pharma said it has dispatched the first batch of generic remdesivir for drugmaker Cipla Ltd, as the country recorded more than 22,000 new coronavirus cases on T...
Syndicated Content Jul 07, 2020
Cipla gets India approval to sell COVID-19 drug favipiravir
BENGALURU (Reuters) - Cipla Ltd has received Indian regulatory approval to sell anti-viral drug favipiravir to treat COVID-19, the drugmaker said on Friday, as coronavirus infections in the world's th...
Syndicated Content Jul 24, 2020
New DARPin drugs show promise, 'good' cholesterol tied to lower risk
By Nancy Lapid (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by ...
Syndicated Content Feb 05, 2021
Current Weather
Wausau, WI, USA
61 °F Partly cloudy